ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 36 filers reported holding ATYR PHARMA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $303,000 | +1.0% | 114,449 | +33.5% | 0.00% | – |
| Q4 2017 | $300,000 | -29.1% | 85,750 | +2.3% | 0.00% | – |
| Q3 2017 | $423,000 | +110.4% | 83,848 | +44.1% | 0.00% | – |
| Q2 2017 | $201,000 | -1.5% | 58,172 | 0.0% | 0.00% | – |
| Q1 2017 | $204,000 | +71.4% | 58,172 | +5.1% | 0.00% | – |
| Q4 2016 | $119,000 | -32.4% | 55,372 | 0.0% | 0.00% | – |
| Q3 2016 | $176,000 | – | 55,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $3,930,000 | 4.66% |
| EcoR1 Capital, LLC | 976,986 | $2,101,000 | 0.67% |
| TANG CAPITAL MANAGEMENT LLC | 279,425 | $601,000 | 0.32% |
| Rock Springs Capital Management LP | 475,000 | $1,021,000 | 0.07% |
| Quotient Investors, LLC | 22,200 | $48,000 | 0.03% |
| Alyeska Investment Group, L.P. | 1,072,108 | $2,305,000 | 0.02% |
| TIVERTON ASSET MANAGEMENT LLC | 95,318 | $205,000 | 0.01% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 79,677 | $171,000 | 0.01% |
| Acrospire Investment Management LLC | 12,683 | $27,000 | 0.01% |
| Glen Harbor Capital Management LLC | 179,724 | $386,000 | 0.01% |